Objective: Older adults are more susceptible than the general population to developing metabolic syndrome (i.e., three or more cardiovascular risk factors [MetS]), physical limitations, and traumatic brain injury (TBI). Recent research has demonstrated that cognition may moderate the negative association between MetS and mobility dysfunction in older adults. This study sought to determine if cognition mediates the relationship between MetS and mobility dysfunction and if this relationship differs in older adults with a history of TBI.

Method: Participants ( = 20,156) were from the National Alzheimer's Coordinating Center's Uniform Data Set. Mediation models were tested to assess if processing speed, executive functioning, immediate memory, and delayed memory would independently mediate the association between MetS and mobility dysfunction.

Results: Investigation of mediation models revealed that MetS had a significant indirect effect on mobility dysfunction through processing speed ( = .0674, 95% CI [.0412, .0953]) and executive functioning ( = .0354, 95% CI [.0228, .0493]). When TBI was included in the model as a moderator, MetS was not found to moderate the mediating effects of any of the cognitive variables. There were no significant indirect effects for immediate or delayed memory in either model.

Conclusions: Findings elucidate potential pathways by which MetS contributes to mobility dysfunction in older adults through specific reductions in processing speed and executive functioning capabilities. (PsycInfo Database Record (c) 2025 APA, all rights reserved).

Download full-text PDF

Source
http://dx.doi.org/10.1037/neu0000980DOI Listing

Publication Analysis

Top Keywords

mobility dysfunction
20
older adults
20
dysfunction older
12
mets mobility
12
processing speed
12
executive functioning
12
metabolic syndrome
8
traumatic brain
8
brain injury
8
association mets
8

Similar Publications

Introduction: Early mobilization reduces long-term muscle weakness after intensive care unit (ICU) admission, but barriers (e.g., anxiety, lack of motivation) may complicate patients' adherence to exercise.

View Article and Find Full Text PDF

The aim is to assess the associations of jaw functional limitation and jaw overuse behavior with pain modified by function as a required diagnostic criterion for painful temporomandibular disorders. This cross-sectional study from the TMJ Impact Project utilized secondary data analyses of 249 participants who met the inclusion criteria of having facial pain in the prior 30 days and valid responses to the pain modified by function (Items 4A-D derived from the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Symptom Questionnaire). Independent -tests (alpha = 0.

View Article and Find Full Text PDF

Purpose: While treatment modalities for Maisonneuve fractures involving the proximal third of the fibula are established, no studies to date have reported outcomes associated with syndesmotic-only fixation of middle third fibular shaft fractures. The purpose of this study was to evaluate outcomes associated with syndesmotic-only fixation in the treatment of Maisonneuve fractures involving the middle third of the fibula.

Methods: A retrospective review was conducted on 257 cases of syndesmotic ankle instability with associated fibular fractures at a level 1 trauma center between 2013 and 2023.

View Article and Find Full Text PDF

Background: Community mobility is a vital patient-centered outcome for older adults living in the community. These deficits in mobility are linked to social isolation, increased hospitalizations, and higher mortality rates. Impaired pulmonary function may be a modifiable risk factor for mobility decline, with existing inequities in lung health potentially contributing disproportionately to mobility loss among Black older adults.

View Article and Find Full Text PDF

The Receptor for Advanced Glycation End Products (RAGE), part of the immunoglobulin superfamily, plays a significant role in various essential functions under both normal and pathological conditions, especially in the progression of Alzheimer's disease (AD). RAGE engages with several damage-associated molecular patterns (DAMPs), including advanced glycation end products (AGEs), beta-amyloid peptide (Aβ), high mobility group box 1 (HMGB1), and S100 calcium-binding proteins. This interaction impairs the brain's ability to clear Aβ, resulting in increased Aβ accumulation, neuronal injury, and mitochondrial dysfunction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!